Cite
HARVARD Citation
Cork, M. et al. (2020). Dupilumab in adolescents with uncontrolled moderate‐to‐severe atopic dermatitis: results from a phase IIa open‐label trial and subsequent phase III open‐label extension. British journal of dermatology. pp. 85-96. [Online].